Sanofi partnership brings global research development to Gold Coast

October 13, 2023

New Griffith University site for the Translational Science Hub brings global vaccine R&D to the Gold Coast.

Image: Dr Iris Depaz, Managing Director TSH & Country Medical Lead, Sanofi AuNZ, Vice Chancellor and President Professor Carolyn Evans, Griffith University, Acting Deputy Director General, Mark Tierney – Queensland State Government. Supplied.

Sanofi, one of the world’s leading healthcare companies, has  progressed its partnership with Griffith University by officially opening its latest research  site at the university’s Gold Coast campus, which will bring global biomedical research  and development (R&D) to the Coast.  

The partnership forms part of the Translational Science Hub (TSH), an exciting  collaboration that links world-class researchers in Queensland, and now the Gold Coast, with scientists at the Sanofi mRNA Centre of Excellence in France and the United States  to develop the next generation of immunisations.  

A first of its kind, TSH is a $280 million partnership between Sanofi, the Queensland  Government, Griffith University, and the University of Queensland that is putting the  Sunshine State at the forefront of mRNA vaccine development and biomedical research  in Australia. 

Operating at the cutting-edge of science, Griffith University offers state-of-the art  technology and leading experts in infectious disease, vaccine development and mRNA  technology, presenting strong foundations for successful research collaboration in  mRNA science. 

“Queensland is home to world-class research facilities and a highly-skilled workforce driving the development of new vaccines and healthcare  breakthroughs,” says Queensland Deputy Premier, Hon. Steven Miles MP.

“The fact that Sanofi, one of the world’s largest healthcare  companies, chose Queensland to reshape 21st century medicine is a strong  sign of things to come, and a significant milestone for the Gold Coast and  Griffith University.”

The Translational Science Hub will initially focus on the evaluation of a new generation  of mRNA vaccines. mRNA is expected to herald new vaccines that instruct certain cells  to produce proteins that are recognised by the immune system to mount a defence. 

“This partnership sees Griffith University as a burgeoning biotech hub on the  Gold Coast,” says Vice Chancellor and President Professor Carolyn Evans, Griffith University.

Researchers based on the Gold Coast will use Griffith University infrastructure and  technology to better understand mRNA vaccine technology, which will help to optimise  the platform to produce better vaccines and expand its use in the development of  therapies to treat a variety of diseases.  

First-of-its-kind vaccines for chlamydia, acne and even some cancers, plus improved  vaccines for influenza and RSV, will be developed on the Gold Coast and across  Queensland.  

Related stories

Leave a Reply

Your email address will not be published. Required fields are marked *